Interesting ImagesPleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate CancerRensi, Marco MD∗; Ferretti, Guido MD∗; Di Gregorio, Fernando MD∗; Evangelista, Laura MD, PhD†Author Information From the ∗Nuclear Medicine Unit, Azienda Sanitaria Universitaria Integrata, Udine †Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV–IRCCS, Padua, Italy. Received for publication September 20, 2018; revision accepted October 25, 2018. Conflicts of interest and sources of funding: none declared. Correspondence to: Laura Evangelista, MD, PhD, Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV–IRCCS, Via Gattamelata, 64 35128 Padua, Italy. E-mail: [email protected]. Clinical Nuclear Medicine: February 2019 - Volume 44 - Issue 2 - p e116-e117 doi: 10.1097/RLU.0000000000002416 Buy Erratum Metrics Abstract A 73-year-old man with a prostate cancer treated by radical prostatectomy in 2006. For a biochemical recurrence of disease (prostate-specific antigen level, 0.1 ng/mL) during hormonal therapy, patient underwent 18F-choline PET/CT that showed a significant uptake in a diffuse right pleural thickening. The patient was sent to pleurectomy decortication showing an epithelioid pleural mesothelioma. This case highlighted that a histopathological evaluation is mandatory in case of a significant radiolabeled choline uptake in pleural lesions. Erratum The article beginning on page e116 of the February 2019 issue was indexed in an incorrect way in the PDF, on the journal website, and in PubMed: the authors were registered by first name, not by surname. The authors should be listed as follows: Marco Rensi, MD, Guido Ferretti, MD, Fernando Di Gregorio, MD, Laura Evangelista, MD, PhD These corrections have been made in all relevant places online. Clinical Nuclear Medicine. 44(9):769, September 2019. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.